Marcin p. Mycko - Neurology

Author Information

Marcin P. Mycko is a distinguished researcher affiliated with the Department of Neurology at the Faculty of Medicine, University of Warmia and Mazury in Olsztyn, Poland. His work primarily focuses on neurology, with a significant emphasis on multiple sclerosis and related neurological disorders. His research contributions have been recognized in various international forums and publications.

Research Contributions

Marcin P. Mycko has made substantial contributions to the field of neurology, particularly in the area of multiple sclerosis. His research has explored various dimensions of the disease, including the risk of infections associated with disease-modifying treatments, the role of gut microbiota in disease management, and the potential of microRNA and exosome profiling. Additionally, he has investigated the implications of B cell-targeting therapies during the SARS-CoV-2 pandemic and explored novel regulatory mechanisms such as circular RNAs in multiple sclerosis. His work is highly influential in advancing understanding and management of neurological disorders.

Aliases

Marcin P. Mycko is known by several aliases, including M. P. Mycko, M. Mycko, Marcin Mycko, Marcin P Mycko, and Marcin\u2004p. Mycko. These variations reflect different naming conventions used across publications and databases.

Publication and Citation Metrics

Metric	Value
Citation Count	5479
H-index	28
Paper Count	74

Publications:

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.

DOI: 10.1177/13524585211069068

Year: 2022

Multiple Sclerosis

DOI: 10.1212/NXI.0000000000001041

Year: 2021

Gut microbiota modification as an option in multiple sclerosis management

DOI: 10.29089/2020.20.00133

Year: 2020

B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic - when immunosuppression meets infection?

DOI: 10.5603/PJNNS.a2020.0083

Year: 2020

The Heat Shock Protein HSP70 Promotes Th17 Genes’ Expression via Specific Regulation of microRNA

DOI: 10.3390/ijms21082823

Year: 2020

microRNA and exosome profiling in multiple sclerosis

DOI: 10.1177/1352458519879303

Year: 2020

Edaravone, a new therapeutic option in amyotrophic lateral sclerosis: Evaluation of challenges in the drug accessibility

DOI: 10.29089/2020.20.00113

Year: 2020

Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis

DOI: 10.1016/j.jneuroim.2019.576971

Year: 2019

Multiple sclerosis: Serum-derived exosomes express myelin proteins

DOI: 10.1177/1352458517696597

Year: 2018

Heterozygous carriers of germline c.657_661del5 founder mutation in NBN gene are at risk of central nervous system relapse of B-cell precursor acute lymphoblastic leukemia

DOI: 10.3324/haematol.2017.181198

Year: 2018

What is the Prognosis for Parkinson's Disease?

What is Prodromal Parkinson's Disease?

How Does Physical Activity Impact Neurological Health?

How Do Genetic Markers Aid in Treatment?

Are There Cognitive Exercises That Can Help?

Why is it Performed?

How Does Intraoperative MRI Enhance Surgical Outcomes?

How are Comorbid Conditions Managed Preoperatively?

What are Neuroprotective Drugs?

How Does the CNS Communicate with the Body?

Partnered Content Networks

Relevant Topics